Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, United States.
Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, United States.
J Clin Neurosci. 2024 Aug;126:21-25. doi: 10.1016/j.jocn.2024.05.023. Epub 2024 May 31.
Facial nerve hemangiomas (FNHs) are rare tumors that primarily occur near the geniculate ganglion in the temporal bone. Despite their rarity, they can cause significant facial nerve dysfunction. The optimal management approach for FNHs remains uncertain, with surgery being the mainstay but subject to debate regarding the extent of resection and preservation of the facial nerve.
Systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We queried the PubMed/Medline (accessed on 5 March 2024) electronic database using combinations of the following search terms and words text: "geniculate ganglion hemangioma", "ganglional hemangioma", "hemangioma of the facial nerve", "facial hemangioma", and "intratemporal hemangioma".
We identified a total of 30 literatures (321 patients). The most common site involved for the facial nerve hemangioma was the geniculate ganglion area followed by internal auditory canal, tympanic segment, labyrinthine segment and mastoid involvement. All patients were treated with conservative management or surgery. We report a 48-year-old female patient with HB grade 2 facial palsy and hemifacial spasm underwent SRS using Cyberknife technology. The treatment targeted the FNH in the left internal acoustic canal near the geniculate ganglion. Six months post-treatment, clinical improvement was evident, and lesion control was confirmed in a follow-up brain MRI.
The rarity of FNHs contributes to the lack of consensus on optimal management. This illustrative case demonstrates the feasibility of SRS as a standalone treatment for FNHs.
面神经血管瘤(FNH)是一种罕见的肿瘤,主要发生在颞骨内膝状神经节附近。尽管它们很罕见,但它们会导致显著的面神经功能障碍。FNH 的最佳治疗方法仍不确定,手术是主要方法,但关于切除范围和面神经保护仍存在争议。
按照系统评价和荟萃分析的首选报告项目进行系统评价。我们使用以下搜索词和文本词的组合在 PubMed/Medline(2024 年 3 月 5 日访问)电子数据库中进行了查询:“膝状神经节血管瘤”、“神经节血管瘤”、“面神经血管瘤”、“面部血管瘤”和“颞骨内血管瘤”。
我们共确定了 30 篇文献(321 例患者)。面神经血管瘤最常见的受累部位是膝状神经节区域,其次是内听道、鼓膜段、迷路段和乳突受累。所有患者均接受保守治疗或手术治疗。我们报告了 1 例 48 岁女性患者,HB 分级 2 级面瘫和半面痉挛,采用 Cyberknife 技术行 SRS。治疗针对的是位于内听道靠近膝状神经节的左侧面神经血管瘤。治疗后 6 个月,临床改善明显,在后续的脑部 MRI 中确认了病变控制。
FNH 的罕见性导致其最佳治疗方法缺乏共识。这个病例说明了 SRS 作为 FNH 单一治疗方法的可行性。